XLerateHealth raises $2.5M Grant (United States, Oct 2026)
Reach the investors backing rounds like this
Backed by National Institutes of Health · verified emails and LinkedIn on Datapile
XLerateHealth Awarded $2.5 Million NIH Grant To Expand Life Sciences Commercialization Platform - Pulse 2.0
XLerateHealth is a commercialization platform that helps universities, biotech hubs, health systems, and other organizations bring early-stage healthcare and life sciences discoveries to market. They plan to use the NIH grant to expand their software architecture, curriculum, AI tools, and expert marketplace. The platform is designed for institutional partners to manage commercialization programs or license their software.
XLerateHealth Awarded $2.5 Million NIH Grant To Expand Life Sciences Commercialization Platform Pulse 2.0
| Oct 02, 2026 | Supabase | $150.0M | Growth Equity | United States |
| Oct 02, 2026 | SoLa Impact | $93.0M | Debt | United States |
| Oct 02, 2026 | FieldAI | $700.0M | — | United States |
| Oct 02, 2026 | CScale | $145.0M | Series C | United States |
21,556 investors back startups in United States
You just read who funded XLerateHealth. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.